182 related articles for article (PubMed ID: 35999867)
1. Investigation for the efficacy of COVID-19 vaccine in Japanese CKD patients treated with hemodialysis.
Yoshifuji A; Toda M; Ryuzaki M; Kikuchi K; Kawai T; Sakai K; Oyama E; Koinuma M; Katayama K; Uehara Y; Ohmagari N; Kanno Y; Kon H; Shinoda T; Takano Y; Tanaka J; Hora K; Nakazawa Y; Hasegawa N; Hanafusa N; Hinoshita F; Morikane K; Wakino S; Nakamoto H; Takemoto Y
Ren Replace Ther; 2022; 8(1):39. PubMed ID: 35999867
[TBL] [Abstract][Full Text] [Related]
2. Anti-SARS-CoV-2 IgG antibody titer after BNT162b2 mRNA COVID-19 vaccination in Japanese patients who underwent renal replacement therapy, hemodialysis, peritoneal dialysis, and kidney transplantation.
Iwabuchi R; Harada M; Yamada A; Aomura D; Yamada Y; Sonoda K; Nakazawa H; Sakai K; Mizukami E; Hashimoto K; Kamijo Y
Clin Exp Nephrol; 2023 Aug; 27(8):660-671. PubMed ID: 37095343
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan.
Kanai D; Wakui H; Haze T; Azushima K; Kinguchi S; Tsukamoto S; Kanaoka T; Urate S; Toya Y; Hirawa N; Kato H; Watanabe F; Hanaoka K; Hanaoka M; Mitsuhashi H; Yamaguchi S; Ohnishi T; Tamura K
Clin Exp Nephrol; 2022 Oct; 26(10):988-996. PubMed ID: 35751753
[TBL] [Abstract][Full Text] [Related]
4. Antibody Response and Safety After mRNA-1273 SARS-CoV-2 Vaccination in Peritoneal Dialysis Patients - the Vienna Cohort.
Beilhack G; Monteforte R; Frommlet F; Gaggl M; Strassl R; Vychytil A
Front Immunol; 2021; 12():780594. PubMed ID: 34925359
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis.
Bensouna I; Caudwell V; Kubab S; Acquaviva S; Pardon A; Vittoz N; Bozman DF; Hanafi L; Faucon AL; Housset P
Am J Kidney Dis; 2022 Feb; 79(2):185-192.e1. PubMed ID: 34508833
[TBL] [Abstract][Full Text] [Related]
6. Comparison of antibody response following the second dose of SARS-CoV-2 mRNA vaccine in elderly patients with late-stage chronic kidney disease.
Matsunami M; Suzuki T; Fukuda J; Terao T; Ukai K; Sugihara S; Toishi T; Nagaoka K; Nakata M; Ohara M; Yashima J; Kuji H; Matsue K
Ren Replace Ther; 2022; 8(1):13. PubMed ID: 35402003
[TBL] [Abstract][Full Text] [Related]
7. T-Cell Response and Antibody Production Induced by the COVID-19 Booster Vaccine in Japanese Chronic Kidney Disease Patients Treated with Hemodialysis.
Yoshifuji A; Toda M; Ryuzaki M; Oyama E; Kikuchi K; Kawai T; Sakai K; Koinuma M; Katayama K; Yokoyama T; Uehara Y; Ohmagari N; Kanno Y; Kon H; Shinoda T; Takano Y; Tanaka J; Hora K; Nakazawa Y; Hasegawa N; Hanafusa N; Hinoshita F; Morikane K; Wakino S; Nakamoto H; Takemoto Y
Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992238
[TBL] [Abstract][Full Text] [Related]
8. Long-term trajectories of SARS-CoV-2 neutralizing antibodies and predictive value of first dose vaccination-induced IgG-antibodies in hemodialysis patients.
Tillmann FP; Still H; von Landenberg P
Int Urol Nephrol; 2022 Aug; 54(8):1939-1945. PubMed ID: 34860338
[TBL] [Abstract][Full Text] [Related]
9. Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.
Choi JH; Kim YR; Heo ST; Oh H; Kim M; Lee HR; Yoo JR
Front Immunol; 2022; 13():827306. PubMed ID: 35173736
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
Front Immunol; 2021; 12():690698. PubMed ID: 34276681
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of neutralizing antibody titers of the SARS-CoV-2 vaccine in maintenance hemodialysis patients.
Amari Y; Morimoto S; Teranishi T; Motoike Y; Yurugi T; Oyama Y; Nakajima F; Kobayashi H
Clin Nephrol; 2024 Jun; 101(6):271-276. PubMed ID: 38497683
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with anti-SARS-CoV-2 spike antibody titers after a second BNT162b2 mRNA COVID-19 vaccination in Japanese hemodialysis patients.
Hirai K; Shimotashiro M; Sonoda T; Okumura T; Ookawara S; Morishita Y
Clin Exp Nephrol; 2022 Sep; 26(9):925-932. PubMed ID: 35426594
[TBL] [Abstract][Full Text] [Related]
13. Immune response to the mRNA COVID-19 vaccine in hemodialysis patients: cohort study.
Chang YS; Huang K; Lee JM; Vagts CL; Ascoli C; Amin MR; Ghassemi M; Lora CM; Edafetanure-Ibeh R; Huang Y; Cherian RA; Sarup N; Warpecha SR; Hwang S; Goel R; Turturice BA; Schott C; Hernandez M; Chen Y; Joregensen J; Wang W; Rasic M; Novak RM; Finn PW; Perkins DL
medRxiv; 2023 Jan; ():. PubMed ID: 36711520
[TBL] [Abstract][Full Text] [Related]
14. Investigation of IgG Titers in Hemodialysis Patients and Controls Following Administration of the COVID-19 Vaccine.
Jozpanahi M; Jafari R; Moharrer M; Mahmoudi P; Saeed SP; Dinmohammadi H
Int Tinnitus J; 2024 Mar; 27(2):183-190. PubMed ID: 38507633
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the SARS-CoV-2 Antibody Response to the BNT162b2 Vaccine in Patients Undergoing Hemodialysis.
Yau K; Abe KT; Naimark D; Oliver MJ; Perl J; Leis JA; Bolotin S; Tran V; Mullin SI; Shadowitz E; Gonzalez A; Sukovic T; Garnham-Takaoka J; de Launay KQ; Takaoka A; Straus SE; McGeer AJ; Chan CT; Colwill K; Gingras AC; Hladunewich MA
JAMA Netw Open; 2021 Sep; 4(9):e2123622. PubMed ID: 34473256
[TBL] [Abstract][Full Text] [Related]
16. Low humoral immune response to the BNT162b2 vaccine against COVID-19 in nursing home residents undergoing hemodialysis: a case-control observational study.
Kitamura M; Takazono T; Yamamoto K; Harada T; Funakoshi S; Mukae H; Nishino T
Ren Replace Ther; 2022; 8(1):8. PubMed ID: 35308296
[TBL] [Abstract][Full Text] [Related]
17. Short-term antibody response after 1 dose of BNT162b2 vaccine in patients receiving hemodialysis.
Goupil R; Benlarbi M; Beaubien-Souligny W; Nadeau-Fredette AC; Chatterjee D; Goyette G; Gunaratnam L; Lamarche C; Tom A; Finzi A; Suri RS;
CMAJ; 2021 May; 193(22):E793-E800. PubMed ID: 33980499
[TBL] [Abstract][Full Text] [Related]
18. Antibody Response and Adverse Events of AZD1222 COVID-19 Vaccination in Patients Undergoing Dialysis: A Prospective Cohort Study.
Wang HH; Wu JL; Chang MY; Wu HM; Ho LC; Chi PJ; Wu CF; Lee WC; Liou HH; Hung SY; Lee YC
Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146538
[TBL] [Abstract][Full Text] [Related]
19. Early Humoral Responses of Hemodialysis Patients After Inactivated SARS-CoV-2 Vaccination.
Zhao WM; Shi R; Wang P; He J; Chen Y; Feng YT; Pan HF; Wang DG
J Inflamm Res; 2022; 15():3467-3475. PubMed ID: 35726214
[TBL] [Abstract][Full Text] [Related]
20. The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients.
Zitt E; Davidovic T; Schimpf J; Abbassi-Nik A; Mutschlechner B; Ulmer H; Benda MA; Sprenger-Mähr H; Winder T; Lhotta K
Front Immunol; 2021; 12():704773. PubMed ID: 34220867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
